ERBB2 and breast cancer: In the mice model, luminal A breast cancer cell line T47D (ER+ PR+ HER2−) was planted in the footpad, expression level discrepancies in ER and PR within primary tumors were evident, while HER2 overexpression emerged in one of eight footpad primary tumors.